Aibin Liang
- Molecular Biology
- Oncology top 5%
- Genetics top 5%
- Immunology
- Cancer Research top 10%
- Topics
- CAR-T cell therapy research (44 papers)Acute Myeloid Leukemia Research (19 papers)Lymphoma Diagnosis and Treatment (19 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Aibin Liang
104 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 111
- Molecular Biology 689
- Oncology 498
- Genetics 247
- Immunology 202
- Cancer Research 182
Countries citing papers authored by Aibin Liang
This map shows the geographic impact of Aibin Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aibin Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aibin Liang more than expected).
Fields of papers citing papers by Aibin Liang
This network shows the impact of papers produced by Aibin Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aibin Liang. The network helps show where Aibin Liang may publish in the future.
Co-authorship network of co-authors of Aibin Liang
This figure shows the co-authorship network connecting the top 25 collaborators of Aibin Liang. A scholar is included among the top collaborators of Aibin Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aibin Liang. Aibin Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 3 | |
| 6 | 4 | |
| 7 | 9 | |
| 8 | 0 | |
| 9 | 11 | |
| 10 | 3 | |
| 11 | 0 | |
| 12 | 9 | |
| 13 | 12 | |
| 14 | 2 | |
| 15 | 2 | |
| 16 | 1 | |
| 17 | 1 | |
| 18 | 5 | |
| 19 | 10 | |
| 20 | 5 |
About Aibin Liang
Aibin Liang is a scholar working on Hematology, Oncology and Genetics, having authored 117 papers that have together received 1.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (44 papers), Acute Myeloid Leukemia Research (19 papers) and Lymphoma Diagnosis and Treatment (19 papers). The work is most often cited by research in Genetics (247 citations), Oncology (498 citations) and Urology (87 citations). Aibin Liang has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Wenjun Zhang, Yu Fang, Yao Sun, Junjun Liu, Jianhua Yang, Beizhan Jiang, Guo‐Tong Xu, Bing Xiu, Ping Li and Wenbin Qian. Their work appears in journals such as Advanced Materials, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.